Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Evoke Pharma Company Profile (NASDAQ:EVOK)

Consensus Ratings for Evoke Pharma (NASDAQ:EVOK) (?)
Ratings Breakdown: 4 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.20)
Consensus Price Target: $29.25 (316.67% upside)

Analysts' Ratings History for Evoke Pharma (NASDAQ:EVOK)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/27/2014Cantor FitzgeraldReiterated RatingBuy$19.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2014Feltl & Co.Initiated CoverageStrong-BuyViewTweet This Rating  Share This Rating on StockTwits
4/22/2014LaidlawInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
4/22/2014LaidlawInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Ascendiant Capital MarketsInitiated CoverageBuy$18.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013AegisInitiated CoverageBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2013Cantor FitzgeraldInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2012 forward)